Back to search
Dyskinesia
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Dyskinesia trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Dyskinesia trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This is a first-in-human (FIH) study of RG6496 that will assess the safety and tolerability of single-ascending doses of RG6496 administered to huntington's dis…
This is a single-center, open-label study designed to evaluate the feasibility, safety, and preliminary efficacy of cerebellar adaptive deep brain stimulation (…
For participation in this epidemiological study, a single-day visit at the study site is required. Participants will be recruited from Huntington Disease clinic…
Background: Tics are involuntary movements and vocalizations. Some tics are organic: They are related to diagnosed disorders. Sometimes tics have other causes,…
The overall short-term goals of this project include the following: 1) identify the genes that are key to the function of respiratory cilia to protect the norma…
The goal of this clinical trial is to test if the drug SKY-0515, an oral medication, can lower harmful proteins linked to Huntington's Disease (HD) and improve…
Adult participants with spinocerebellar ataxia type 2 (SCA2) who carry ≥33 cytosine, adenine, guanine (CAG) repeats in the ATXN2 gene, and who have met all prot…
The purpose of this study is to learn more about how mindfulness techniques can help reduce anxiety, depression and body image disturbance as well as improve sy…